$HAE 8-K SEC Filings

Filed On	Filing
08 Oct 2026	8-K: Regulation FD Disclosure On August 18, 2026, Haemonetics Corporation (the “Company”) furnished a Current Report on Form 8-K disclosing its entry into a non-exclusive supply agreement with CSL Plasma Inc. (“CSL”), under which CSL may utilize the Company’s NexSys ...
18 Aug 2026	8-K: Regulation FD Disclosure
06 Aug 2026	8-K: Results of Operations and Financial Condition
28 Jul 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
05 Jun 2026	8-K: Regulation FD Disclosure
07 May 2026	8-K: Results of Operations and Financial Condition
01 May 2026	8-K: Departure/Election of Directors or Officers; Compensation
03 Mar 2026	8-K: Regulation FD Disclosure
12 Feb 2026	8-K: Regulation FD Disclosure
05 Feb 2026	8-K: Results of Operations and Financial Condition
09 Jan 2026	8-K: Other Events
06 Nov 2025	8-K: Results of Operations and Financial Condition
07 Aug 2025	8-K: Results of Operations and Financial Condition
25 Jul 2025	8-K: Submission of Matters to a Vote of Security Holders
08 May 2025	8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities
03 Mar 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
06 Feb 2025	8-K: Results of Operations and Financial Condition
14 Jan 2025	8-K: Other Events
03 Jan 2025	8-K: Departure/Election of Directors or Officers; Compensation
03 Dec 2024	8-K: Other Events

Comments